Late effects of sleep restriction: Potentiating weight gain and insulin resistance arising from a high-fat diet in mice

Obesity

Volumn 23, Issue 2, 2015, Pages 391-398

  De Oliveira, Edson Mendes ^a   Visniauskas, Bruna ^b   Sandri, Silvana ^a   Migliorini, Silene ^a   Andersen, Monica Levy ^b   Tufik, Sergio ^b   Fock, Ricardo Ambrõsio ^a   Chagas, Jair Ribeiro ^b   Campa, Ana ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; GLYCEROL; INSULIN; INTERLEUKIN 6; LEPTIN; MESSENGER RNA; PERILIPIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RESISTIN; RNA 18S; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C/EBPALPHA GENE; C/EBPBETA GENE; CELL INFILTRATION; CONTROLLED STUDY; DIET INDUCED OBESITY; DISEASE PREDISPOSITION; EPIDIDYMIS FAT; FAT MASS; FOOD COMPOSITION; GENE; GENE EXPRESSION; GLUCOSE TOLERANCE; GLYCEROL BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID DIET; MACROPHAGE; MALE; MOUSE; NONHUMAN; PPARGAMMA GENE; PROTEIN EXPRESSION; RETROPERITONEAL FAT; SLEEP DEPRIVATION; SUBCUTANEOUS FAT; WEIGHT GAIN; WHITE ADIPOSE TISSUE; ADIPOSE TISSUE; ADVERSE EFFECTS; ANIMAL; BODY WEIGHT; C57BL MOUSE; COMPLICATION; DISEASE MODEL; FOLLOW UP; METABOLISM; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME;

MUS;

ADIPOSE TISSUE; ANIMALS; BODY WEIGHT; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; FOLLOW-UP STUDIES; INSULIN; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; OBESITY; SLEEP DEPRIVATION; TIME FACTORS; WEIGHT GAIN;

EID: 84922744612     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20970     Document Type: Article

References (40)

1. Cani PD, Bibiloni R, Knauf C, Neyrinck AM, Delzenne NM, Burcelin R,. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008; 57: 1470-1481.
2. Trasande L, Blustein J, Liu M, Corwin E, Cox LM, Blaser MJ,. Infant antibiotic exposures and early-life body mass. Int J Obes 2013; 37: 16-23.
3. Gabbert C, Donohue M, Arnold J, Schwimmer JB,. Adenovirus 36 and obesity in children and adolescents. Pediatrics 2010; 126: 721-726.
4. Hegde V, Dhurandhar NV,. Microbes and obesity-interrelationship between infection, adipose tissue and the immune system. Clin Microbiol Infect 2013; 19: 314-320.
5. Suliburska J, Cofta S, Gajewska E, et al. The evaluation of selected serum mineral concentrations and their association with insulin resistance in obese adolescents. Eur Rev Med Pharmacol Sci 2013; 17: 2396-2400.
6. Knutson KL,. Does inadequate sleep play a role in vulnerability to obesity? Am J Hum Biol 2012; 24: 361-371.
7. Hairston KG, Bryer-Ash M, Norris JM, Haffner S, Bowden DW, Wagenknecht LE,. Sleep duration and five-year abdominal fat accumulation in a minority cohort: The IRAS family study. Sleep 2010; 33: 289-295.
8. Watanabe M, Kikuchi H, Tanaka K, Takahashi M,. Association of short sleep duration with weight gain and obesity at 1-year follow-up: A large-scale prospective study. Sleep 2010; 33: 161-167.
9. Chaput JP, Despres JP, Bouchard C, Tremblay A,. The association between sleep duration and weight gain in adults: A 6-year prospective study from the Quebec Family Study. Sleep 2008; 31: 517-523.
10. Tasali E, Leproul R, Ehrmann DA, Van Cauter E,. Slow-wave sleep and the risk of type 2 diabetes in humans. Proc Natl Acad Sci US A 2008; 105: 1044-1049.
11. Barf RP, Meerlo P, Scheurink AJW,. Chronic Sleep Disturbance Impairs Glucose Homeostasis in Rats. Int J Endocrinol 2010.
12. Copinschi G, Leproult R, Spiegel K,. The Important Role of Sleep in Metabolism. Front Horm Res 2014; 42: 13.
13. Zimberg IZ, Damaso A, Del Re M, et al. Short sleep duration and obesity: mechanisms and future perspectives. Cell Biochem Funct 2012; 30: 524-529.
14. Padilha HG, Crispim CA, Zimberg IZ, et al. A link between sleep loss, glucose metabolism and adipokines. Braz J Med Biol Res 2011; 44: 992-999.
15. Broussard JL, Ehrmann DA, Van Cauter E, Tasali E, Brady MJ,. Impaired insulin signaling in human adipocytes after experimental sleep restriction a randomized, crossover study. Ann Intern Med 2012; 157: 549-558.
16. Klingenberg L, Chaput J-P, Holmback U, et al. Acute sleep restriction reduces insulin sensitivity in adolescent boys. Sleep 2013; 36: 1085-1090.
17. Wang Y, Carreras A, Lee S, et al. Chronic sleep fragmentation promotes obesity in young adult mice. Obesity 2014; 22: 758-762.
18. Vetrivelan R, Fuller PM, Yokota S, Lu J, Saper CB,. Metabolic effects of chronic sleep restriction in rats. Sleep 2012; 35: 1511-1520.
19. Machado RB, Hipolide DC, Benedito-Silva AA, Tufik S,. Sleep deprivation induced by the modified multiple platform technique: quantification of sleep loss and recovery. Brain Res 2004; 1004: 45-51.
20. Leemburg S, Vyazovskiy VV, Olcese U, Bassetti CL, Tononi G, Cirelli C,. Sleep homeostasis in the rat is preserved during chronic sleep restriction. Proc Natl Acad Sci U S A 2010; 107: 15939-15944.
21. Clasadonte J, McIver SR, Schmitt LI, Halassa MM, Haydon PG,. Chronic sleep restriction disrupts sleep homeostasis and behavioral sensitivity to alcohol by reducing the extracellular accumulation of adenosine. J Neurosci 2014; 34: 1879-1891.
22. Filippin-Monteiro FB, de Oliveira EM, Sandri S, Knebel FH, Albuquerque RC, Campa A,. Serum amyloid A is a growth factor for 3T3-L1 adipocytes, inhibits differentiation and promotes insulin resistance. Int J Obes 2012; 36: 1032-1039.
23. Knutson KL, Van Cauter E, Zee P, Liu K, Lauderdale DS,. Cross-sectional associations between measures of sleep and markers of glucose metabolism among subjects with and without diabetes: the Coronary Artery Risk Development in Young Adults (CARDIA) sleep study. Diabetes Care 2011; 34: 1171-1176.
24. Knutson KL, Cauter E,. Associations between sleep loss and increased risk of obesity and diabetes. Ann N Y Acad Sci 2008; 1129: 287-304.
25. Andersen ML, Martins PJF, D'Almeida V, Bignotto M, Tufik S,. Endocrinological and catecholaminergic alterations during sleep deprivation and recovery in male rats. J Sleep Res 2005; 14: 83-90.
26. Hipolide DC, Suchecki D, Pinto APD, Faria EC, Tufik S,. Paradoxical sleep deprivation and sleep recovery: Effects on the hypothalamic-pituitary-adrenal axis activity, energy balance and body composition of rats. J Neuroendocrinol 2006; 18: 231-238.
27. Martins PJF, Marques MS, Tufik S, D'Almeida V,. Orexin activation precedes increased NPY expression, hyperphagia, and metabolic changes in response to sleep deprivation. Am J Physiol Endocrinol Metab 2010; 298: E726-E734.
28. Chen XH, Iqbal N, Boden G,. The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. J Clin Invest 1999; 103: 365-372.
29. Barf RP, Van Dijk G, Scheurink AJW, et al. Metabolic consequences of chronic sleep restriction in rats: Changes in body weight regulation and energy expenditure. Physiol Behav 2012; 107: 322-328.
30. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW,. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808.
31. Sartipy P, Loskutoff DJ,. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci USA 2003; 100: 7265-7270.
32. Samad F, Loskutoff DJ,. Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice. Mol Med 1996; 2: 568-582.
33. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS,. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997; 389: 610-614.
34. Harsch IA, Koebnick C, Wallaschofski H, et al. Resistin levels in patients with obstructive sleep apnoea syndrome-the link to subclinical inflammation? Med Sci Monit 2004; 10: CR510-CR515.
35. Yamamoto Y, Fujiuchi S, Hiramatsu M, et al. Resistin is closely related to systemic inflammation in obstructive sleep apnea. Respiration 2008; 76: 377-385.
36. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ,. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005; 111: 932-939.
37. Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature 2001; 409: 307-312.
38. Husse J, Hintze SC, Eichele G, Lehnert H, Oster H,. Circadian clock genes Per1 and Per2 regulate the response of metabolism-associated transcripts to sleep disruption. Plos One 2012; 7.
39. Weisberg SP, Hunter D, Huber R, et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 2006; 116: 115-124.
40. Hamm JK, Park BH, Farmer SR,. A role for C/EBP beta in regulating peroxisome proliferator-activated receptor gamma activity during adipogenesis in 3T3-L1 preadipocytes. J Biol Chem 2001; 276: 18464-18471.